Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Prednisolone × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Follicular 4 Lymphoma 4 Burkitt Lymphoma 4 Ovarian Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Neoplasms 2 Neoplasm Metastasis 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hodgkin Disease 2 Endometrial Neoplasms 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Myasthenia Gravis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Immunoblastic Lymphadenopathy 1 Heart Failure 1 Esophageal Stenosis 1 Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡